FLT3 and acute myeloid leukemia: In animal issue, we proved that CD44v6 CAR‐T cells were an efficacious therapy for AML with FLT3 mutations in cell derived xenograft (CDX) animal models with the FLT3 mutated MV4‐11 and FLT3/ITD knock‐in SKM‐1 cells.